HNN3.0

Project cooperationUpdated on 22 January 2026

Microbiome analysis towards clinical practice

CEO at SeqBiome

Dublin, Ireland

About

Seqbiome is an end-to-end research business, providing tailored solutions in questions involving the microbiome. With extensive experience, excellent tools and capabilities, our customers value our ability to translate their questions into appropriate studies and relevant, high quality outputs, e.g., publications, regulatory submissions, patents. We have generated a number of focused tools in Gut Health and Women's Health that serve as precursors to researching in areas of specific unmet clinical need that can support therapeutic or other interventions as companion or complementary diagnosis/analysis.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Type

  • Partner seeks Consortium/Coordinator

Organisation

SeqBiome

Company (SME)

Cork, Ireland

Similar opportunities